A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria

Adjunctive perampanel for refractory partial-onset seizures

Jacqueline A. French, Gregory L. Krauss, Victor Biton et al. · Neurology · 2012 · 477 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Randomized phase III study 306

Gregory L. Krauss, José M. Serratosa, Vicente Villanueva et al. · Neurology · 2012 · 429 citations

Medicine, Pharmacology, Pharmacotherapy +15

Evaluation of adjunctive perampanel in patients with refractory partial‐onset seizures: Results of randomized global phase III study 305

Jacqueline A. French, Gregory L. Krauss, Bernhard J. Steinhoff et al. · Epilepsia · 2012 · 426 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Perampanel: A novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy

Takahisa Hanada, Yutaka Hashizume, Naoki Tokuhara et al. · Epilepsia · 2011 · 408 citations · Full text

Medicine, Neuroscience, Pharmacology +16

Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase <scp>III</scp> studies

Bernhard J. Steinhoff, Elinor Ben‐Menachem, Philippe Ryvlin et al. · Epilepsia · 2013 · 263 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15